Status:
COMPLETED
Neopep-S Ingredient Easy Dew MD Regen Cream
Lead Sponsor:
Eun-ji Kim
Conditions:
Dry Skin
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
The purpose of this clinical study is to provide patients diagnosed with dry skin due to various causes such as atopic dermatitis and Yangjin The effect on skin regeneration after applying EasyDew MD ...
Detailed Description
The total study period for this clinical study is 12 months from the date of IRB approval, led by researchers from a single institution It's a clinical study. The individual participation period of th...
Eligibility Criteria
Inclusion
- Subjects diagnosed with xerotic skin among adults aged 19 to 80 years
- Subjects who have voluntarily decided to participate in this clinical study and signed a written informed consent
Exclusion
- Subjects with uncontrolled diabetes
- Immunosuppressants, corticosteroids, cytotoxic drugs, anticoagulants, etc. are included in the results You are on long-term or scheduled to receive medication that may affect you a person who is subject to
- Acute or chronic skin disease; stage in progress or active in the area of application Subject to bacterial or viral infection
- Where the researcher's judgment determines that participation in the study is inappropriate
Key Trial Info
Start Date :
November 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05982535
Start Date
November 11 2022
End Date
July 27 2023
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Hospital
Gyeonggi-do, South Korea